Correction to: European Journal of Clinical Pharmacology

https://doi.org/10.1007/s00228-019-02726-w

The original publication of this paper contains two errors. We apologize for any inconvenience this may have caused.

1. The Median (Q25–Q75) of dose-adjusted C0 of tacrolimus for the two genotypes of CYP3A4*1G, CYP3A4 rs4646437 and CYP3A7 rs10211 in Table 2 should be exchanged. The corrected table 2 is as followed:

SNP

Number

Genotype

Median (Q25–Q75)

p

CYP3A5*3

39

A

54.2(42.3 – 80.0)

0.00006*

31

NA

90.7(65.7 – 171.5)

 

CYP3A4*1G

30

T

59.6(42.8 – 83.1)

0.011

38

NT

82.6(58.5 – 169.7)

 

CYP3A4 rs4646437

11

T

51.7 (32.1 – 91.0)

0.011

56

NT

73.6(54.5 – 133.7)

 

CYP3A7 rs2257401

39

C

62.4(42.6 – 84.9)

0.001*

26

NC

90.7(62.7 – 192.6)

 

CYP3A7 rs10211

34

G

59.6(42.4 – 80.2)

0.0004*

31

NG

101.8(64.2 – 187.3)

 

2. The data “94%” in “the tacrolimus concentration in patients without CYP3A5*3 A allele was 94% higher than those with A allele (90.7 vs 54.2, P = 0.00006).” of the abstract should be “67%”.